Global Blood Therapeutics, Inc. announced that Ted W. Love ceased to be Chief Executive Officer of the Company, effective as of the Closing Date.
Global Blood Therapeutics, Inc.
Equities
GBT
US37890U1088
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |